The positive pregnancy test after IVF is the moment the couple has been working toward — through investigations, protocols, injections, retrievals, transfers, and the particular anguish of the two-week wait. It arrives as a blood test result, typically by phone or in person, and it produces a mixture of emotions that is unlike almost any other clinical moment.
It is not, as many couples expect, a moment of uncomplicated joy. Joy is present — often overwhelmingly so. But alongside it are other emotions: disbelief, anxiety, the fear that the positive result will be taken away, the specific caution of a couple who has learned not to celebrate too early because the clinical journey has already taught them that good news is not always final news.
These emotions are rational. They are the emotional legacy of the infertility journey — the protective caution that develops when hope has been disappointed before. And they deserve to be acknowledged, not dismissed, as part of the transition from the IVF patient into the pregnant patient.
This article is for couples who have received a positive pregnancy test after IVF. It explains what the first trimester after IVF involves — what is monitored, what is different from a naturally conceived first trimester, what the specific risks and reassurances are, and how the transition from the fertility clinic to the obstetric team is managed.
The First Days After a Positive Test: Serial hCG Monitoring
The first clinical action after a positive beta-hCG blood test is serial monitoring of the hCG level — repeated measurements every two to three days to confirm that the level is rising appropriately.
In a normal early pregnancy, hCG approximately doubles every 48 to 72 hours in the first weeks. This doubling pattern — confirmed by serial measurements — provides the first reassurance that the early pregnancy is progressing normally. A hCG that is rising but rising slowly — less than 50 to 66 percent increase over 48 hours — may indicate a pregnancy that is not developing normally, though some normal pregnancies do rise more slowly. A hCG that is not rising, or is falling, indicates a failing pregnancy.
For IVF couples who have experienced previous losses — or who are aware that the first trimester miscarriage rate after IVF is higher than the general population rate, and higher still in older patients — this serial monitoring is both clinically important and emotionally significant. Each rising number is a small confirmation. Each measurement adds to the evidence that the pregnancy is progressing.
At Metro IVF, serial hCG measurements are standard after every positive IVF pregnancy test — typically on day fourteen after transfer (the initial test), day sixteen to seventeen, and day twenty or twenty-one — to confirm the doubling pattern before moving to ultrasound surveillance.
The First Ultrasound: What to Expect
The first ultrasound after IVF is typically scheduled for approximately six to seven weeks of gestation — approximately four to five weeks after the embryo transfer. At this gestational age, a normally progressing IVF pregnancy should show:
A gestational sac — the fluid-filled structure within the uterine cavity that will become the amniotic sac. A gestational sac is visible by transvaginal ultrasound from approximately five weeks.
A yolk sac — the circular structure within the gestational sac that provides initial nutrition to the developing embryo. Visible from approximately five and a half to six weeks.
An embryonic pole — the earliest visible form of the embryo, visible from approximately six weeks.
A fetal heartbeat — the most eagerly awaited finding of the first IVF ultrasound. A fetal heartbeat is normally visible from approximately six weeks of gestation — typically seen as a flickering on transvaginal ultrasound, measured in beats per minute. A normal fetal heart rate at six weeks is approximately ninety to one hundred and ten beats per minute, rising to one hundred and sixty to one hundred and seventy beats per minute by nine to ten weeks.
The significance of the fetal heartbeat for prognosis is substantial. Once a fetal heartbeat is confirmed at six weeks, the ongoing miscarriage risk drops to approximately five to ten percent — substantially lower than the pre-heartbeat risk. For couples who have been living with elevated anxiety since the positive pregnancy test, the confirmation of a fetal heartbeat is the most significant reassurance point of the first trimester.
Location of the pregnancy. The first IVF ultrasound also confirms that the pregnancy is intrauterine — within the uterine cavity — and not ectopic. Ectopic pregnancy — implantation outside the uterus, typically in a fallopian tube — occurs in approximately two to five percent of IVF pregnancies, a higher rate than in natural conception, reflecting the transfer mechanism and any underlying tubal pathology. When the first ultrasound confirms an intrauterine gestational sac, ectopic pregnancy is effectively excluded.
Multiple pregnancy. For couples who transferred a single embryo, the first ultrasound confirms singleton pregnancy in most cases. A small proportion of single embryo transfers — approximately two to three percent — produce monozygotic (identical) twins through spontaneous embryo splitting, and the first ultrasound identifies this. For couples who transferred two embryos — or for donor egg cycles where the number of embryos is the clinical team's decision — the first ultrasound determines how many of the transferred embryos have implanted.
What Is Different About the First Trimester After IVF?
The first trimester of an IVF pregnancy is biologically identical to the first trimester of a naturally conceived pregnancy — the embryo develops through the same stages, the placenta forms through the same mechanisms, and the physiological demands on the pregnant woman are the same. The baby that will result does not know it was conceived through IVF.
What is different is the clinical management, the monitoring intensity, and the psychological experience.
More intensive monitoring. IVF pregnancies are typically monitored more closely in the first trimester than naturally conceived pregnancies — with more frequent ultrasounds, more frequent blood tests, and closer communication with the fertility clinic before the transition to the obstetric team. This additional monitoring is partly driven by the elevated miscarriage risk in the first trimester of IVF pregnancies — particularly in older patients and in pregnancies following multiple failed cycles — and partly by the emotional needs of couples for whom each confirmation of normal progress represents a significant psychological milestone.
Continuing medication. The progesterone supplementation begun after embryo transfer continues through the first trimester — typically until ten to twelve weeks, when the placenta has matured sufficiently to take over progesterone production. As described in our luteal phase support article, stopping progesterone too early — particularly in artificial FET cycles where no corpus luteum provides any natural progesterone backup — risks early pregnancy loss. Progesterone supplementation should not be discontinued without the specific advice of the fertility team.
Additional medications — thyroid medication if thyroid function was optimized before the cycle, aspirin and heparin if antiphospholipid syndrome or thrombophilia was treated — continue as directed by the clinical team.
Elevated anxiety as a normal feature. The psychological experience of the first trimester after IVF is frequently characterized by an anxiety level that is higher than what most naturally conceiving couples describe. This is not irrational. It is the rational emotional response to a journey that has involved significant previous difficulty, that has taught the couple to be cautious with hope, and that continues to carry real clinical uncertainty until the first trimester landmarks — the fetal heartbeat, the nuchal translucency scan, the second-trimester anatomy scan — progressively confirm that the pregnancy is progressing normally.
This anxiety deserves acknowledgment and support rather than dismissal. The injunction to "relax and enjoy the pregnancy" is understandable in intent but frequently unhelpful in practice for couples who have been through infertility and IVF. The anxiety may reduce as each landmark is passed, or it may persist at lower levels through the pregnancy. Either pattern is normal, and professional psychological support — if the anxiety is interfering with daily function — is appropriate and available.
The Nuchal Translucency Scan and First Trimester Screening
At approximately eleven to thirteen weeks of gestation, the nuchal translucency (NT) scan is performed — a standard first-trimester ultrasound that measures the thickness of the fluid at the back of the fetal neck (the nuchal translucency), assesses fetal anatomy at this early stage, confirms the fetal heart rate, and confirms the viability of the pregnancy.
The nuchal translucency measurement, combined with specific blood tests (free beta-hCG and PAPP-A — pregnancy-associated plasma protein A) — and taking into account the mother's age and the gestational age — produces a combined first-trimester screening result that estimates the probability of chromosomal abnormalities in the fetus.
For couples who have undergone PGT-A testing of their embryos before transfer — with confirmed euploid embryo transfer — the risk of chromosomal abnormality in the fetus is substantially lower than for couples who transferred an untested embryo. The NT scan still provides clinically useful information about fetal anatomy and pregnancy viability, but the combined screening interpretation for chromosomal conditions is modified by the known euploid status of the embryo.
For couples who transferred an embryo without PGT-A testing — and particularly for older patients — the combined first-trimester screening result provides the most up-to-date estimate of chromosomal risk and guides decisions about whether to pursue confirmatory diagnostic testing (chorionic villus sampling at eleven to thirteen weeks, or amniocentesis at fifteen to seventeen weeks).
Specific Risks in IVF Pregnancies: What the Evidence Shows
IVF pregnancies are, in most dimensions, clinically comparable to naturally conceived pregnancies. But there are specific areas where the evidence shows modestly elevated risks that deserve clinical awareness and appropriate monitoring.
Preterm birth. IVF singleton pregnancies have a modestly elevated rate of preterm birth compared to naturally conceived singleton pregnancies — approximately six to seven percent versus five percent. The mechanisms are not fully established but may include underlying maternal conditions associated with infertility, the specific hormonal environment of IVF cycles, and the characteristics of couples who undergo IVF. This modest elevation does not require specific interventions beyond standard obstetric monitoring in most singleton IVF pregnancies.
Low birthweight. IVF singletons have a modestly elevated rate of low birthweight — related to the modestly elevated preterm birth rate and possibly to intrauterine growth restriction in some cases. Standard obstetric monitoring with growth scans in the third trimester is appropriate.
Gestational hypertension and pre-eclampsia. IVF pregnancies — particularly frozen embryo transfer pregnancies — may have a modestly elevated risk of hypertensive disorders of pregnancy including pre-eclampsia, possibly related to the absence of the first-trimester corpus luteum and its vasoactive hormonal effects in the placentation process. Blood pressure monitoring throughout the pregnancy is standard.
Placenta praevia. IVF pregnancies have a modestly elevated rate of placenta praevia — the placenta implanting over or near the cervical os — possibly related to the specific location of embryo deposition at transfer. Placental location is assessed at the second-trimester anomaly scan and followed if low-lying.
Congenital abnormalities. The evidence on whether IVF is associated with elevated rates of congenital abnormalities is complex and not fully resolved. Most large-scale studies do not find significantly elevated rates of major structural abnormalities in IVF-conceived children beyond those associated with the underlying conditions that necessitated IVF. Standard anomaly scanning at eighteen to twenty weeks is the appropriate clinical approach.
Transitioning From the Fertility Clinic to the Obstetric Team
One of the most practically significant moments of the IVF first trimester is the transition from the fertility clinic — which has managed the couple's care through the IVF cycle and the early pregnancy monitoring — to the obstetric team that will manage the remainder of the pregnancy.
This transition typically occurs after the first-trimester ultrasound has confirmed a normally progressing pregnancy — most commonly after the NT scan at eleven to thirteen weeks. At this point, the primary clinical management of the pregnancy moves to an obstetrician, and the fertility clinic's direct clinical involvement transitions to consultation on any specific fertility-related issues that arise.
This transition is emotionally significant for many couples — the fertility clinic has been a constant presence through the most difficult part of the journey, and moving to a new clinical team, however appropriate clinically, can feel like a loss of the familiar support structure. Acknowledging this transition explicitly — ensuring the couple knows who to contact with questions, that the fertility clinic remains available for specific concerns, and that the obstetric team has been fully informed of the IVF history and any specific clinical considerations — is part of good clinical continuity of care.
At Metro IVF, the transition to the obstetric team is managed with a specific referral that includes the complete IVF history — the stimulation protocol, the embryo development record, the transfer details, the luteal support medications, the first-trimester monitoring results, and any specific clinical considerations the obstetric team needs to be aware of. This continuity of information ensures that the care the couple receives in the obstetric setting is informed by the complete clinical context of how the pregnancy was achieved.
The Emotional Experience of the IVF First Trimester
The emotional experience of the first trimester after IVF is the emotional experience of a couple who has worked extraordinarily hard for something they were not sure they would achieve — and who are now holding it, tentatively, with the specific mixture of joy and protective caution that very hard-won things produce.
The joy is real. The anxiety is real. The difficulty in fully trusting the positive result — in letting themselves celebrate before the next landmark, and the next, and the next — is real and rational.
What helps: passing each landmark explicitly — the rising hCG, the fetal heartbeat, the NT scan, the anatomy scan — and allowing each one to be a specific moment of relief and recognition. What helps: honest communication between partners about the anxiety, so that it is shared rather than silently managed. What helps: professional support if the anxiety is significantly impairing daily life. And what helps: the accumulating evidence, week by week and scan by scan, that the pregnancy is progressing normally.
The couple who reaches the end of the first trimester with a confirmed, normally progressing pregnancy has crossed the most uncertain and most closely monitored phase of the post-IVF journey. What lies ahead is the rest of a pregnancy — which carries its own specific joys and anxieties, but which, for a couple who has gone through infertility and IVF to reach it, carries a specific and profound meaning that makes the journey, in retrospect, entirely worth everything it involved.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofretility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
The positive test is the beginning of the next chapter. Metro IVF is with you through all of it. Book your consultation with Dr. Ashish Soni today.